Beta-2-microglobulin (B2M) is part of the histocompatibility antigens class I, HLA-ABC, forming a non-covalently bound complex with them.
| Inventor | Institute |
|---|---|
| Francisco Ruíz-Cabello Osuna, Miguel Ángel López-Nevot, Federico Garrido Torres-Puchol | Virgen de las Nieves University Hospital, The Andalusian Health Service |
| Cat. #: | 161696 |
|---|---|
| Tool sub type: | Primary antibody |
| Cancer types: | Blood cancer |
| Research Fields: | Cancer |
| Application: | FACS; IHC; ELISA; WB |
| Target: | Beta-2-microglobulin |
| Reactivity: | Human |
| Clone: | GRH1 |
| Host: | Mouse |
| Class: | Monoclonal |
| Primary citation: | Perea et al. 2017. Int J Cancer. 140(4):888-899. PMID: 27785783 |
| Product description: | Beta-2-microglobulin (B2M) is part of the histocompatibility antigens class I, HLA-ABC, forming a non-covalently bound complex with them. It is expressed in most cells in the body, with very low or undetectable levels in neurons and spermatozoa. |
|---|---|
| Isotype: | IgG1 |
| Molecular weight: | 12 kDa |
| Immunogen: | B-ALL cells |
| Storage buffer: | PBS with 0.02% azide |
|---|---|
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Perea et al. 2017. Int J Cancer. 140(4):888-899. PMID: 27785783 B del Campo. 2014. Int J Cancer. 134(1):102-113. PMID: 23784959 |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151017 | Anti-MBP [R29.6] |
Key Info
Anti-MBP [R29.6]
|
View Tool | |||||||||||||||||||
| 151025 | Anti-Vascular endothelium [10] |
Key Info
Anti-Vascular endothelium [10]
|
View Tool | |||||||||||||||||||
| 151026 | Anti-FCGR1 [10.1] mAb |
Key Info
Anti-FCGR1 [10.1] mAb
|
View Tool | |||||||||||||||||||
| 151038 | Anti-Cytochrome P450 4A2, 4A3 [Clo4] |
Key Info
Anti-Cytochrome P450 4A2, 4A3 [Clo4]
|
View Tool | |||||||||||||||||||
| 151018 | Anti-Mos [R38.1] |
Key Info
Anti-Mos [R38.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.